Sertraline

Overview

Sertraline is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat major depressive disorder, anxiety and certain types of phobia. It functions by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

API suppliers (19)

Suppliers of Sertraline evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• APITORIA PHARMA PRIVATE LTDIndia2 active DMF GMP on record
• Exemed PharmaceuticalsIndia2 active DMF GMP on record
• Viyash Scientific LtdIndia2 active DMF GMP on record
• MATRIX PHARMACORP PRIVATE LTDIndia2 active DMF
• Hetero Drugs LimitedIndia2 active DMF GMP on record
• CHEMECA DRUGS PRIVATE LTDIndia1 active DMF
• Lupin LimitedIndia1 active DMF GMP on record
• Torrent PharmaceuticalsIndia1 active DMF GMP on record
• WANBURY LTDIndia1 active DMF
• AMOLI ORGANICS PRIVATE LTDIndia1 active DMF
• LEE PHARMA LTDIndia1 active DMF GMP on record
• RL FINE CHEM PVT LTDIndia1 active DMF
• R L Fine Chem Pvt. Ltd.India1 active DMF
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• MOEHS IBERICA SLSpain GMP on record
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly GMP on record
• RANBAXY LABORATORIES LTD
• Cipla USA, Inc.USA
• ALP PHARM BEIJING CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (56 approved US products), the latest listed US patent on Sertraline expires — and exclusivity 18 Jan 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas